| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.12B | 94.69B | 82.19B | 79.45B | 70.95B | 61.73B |
| Gross Profit | 41.94B | 37.59B | 33.00B | 28.07B | 23.14B | 18.68B |
| EBITDA | 27.86B | 24.71B | 20.71B | 18.25B | 15.48B | 12.71B |
| Net Income | 16.76B | 14.75B | 11.99B | 10.51B | 8.61B | 6.72B |
Balance Sheet | ||||||
| Total Assets | 300.37B | 307.43B | 276.82B | 245.33B | 210.96B | 195.01B |
| Cash, Cash Equivalents and Short-Term Investments | 46.22B | 39.60B | 34.87B | 39.20B | 31.77B | 33.56B |
| Total Debt | 171.80B | 184.04B | 165.90B | 146.59B | 124.85B | 114.95B |
| Total Liabilities | 192.06B | 204.59B | 185.95B | 163.01B | 138.67B | 129.05B |
| Stockholders Equity | 108.28B | 102.81B | 90.50B | 82.05B | 72.29B | 65.96B |
Cash Flow | ||||||
| Free Cash Flow | -839.15M | -4.52B | -15.11B | 3.72B | -1.59B | -1.17B |
| Operating Cash Flow | -558.71M | -4.36B | -14.92B | 4.13B | -1.51B | -192.53M |
| Investing Cash Flow | 323.26M | -3.82B | -5.52B | -15.83B | -9.08B | -15.45B |
| Financing Cash Flow | 7.86B | 12.90B | 16.12B | 19.13B | 8.79B | 12.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥251.76B | 8.22 | ― | 2.67% | 2.29% | -4.12% | |
74 Outperform | ¥1.26T | 9.43 | 19.43% | 5.16% | 5.16% | 6.00% | |
72 Outperform | ¥1.20T | 9.44 | 19.60% | 1.94% | 3.13% | 11.87% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥167.41B | 3.93 | 14.78% | 2.95% | 17.74% | 19.41% | |
63 Neutral | ¥163.52B | 20.44 | 8.95% | 3.39% | 28.94% | 109.35% | |
57 Neutral | ¥49.84B | -26.35 | ― | 3.75% | -8.66% | -53.57% |